Life threatening hypokalaemia during treatment of severe diltiazem overdose with high dose insulin euglycemic therapy: a case report

Andrew KozmanEmergency Department, Royal Perth Hospital, Perth, Western Australia, AustraliaCorrespondence[email protected]

Kerry HoggettEmergency Department, Royal Perth Hospital, Perth, Western Australia, Australia

Jessamine SoderstromEmergency Department, Royal Perth Hospital, Perth, Western Australia, Australia

References

Levine MD, Boyer E. Hyperinsulinemia-euglycemia therapy: a useful tool in treating calcium channel blocker poisoning. Crit Care. 2006;10(4):149.
PubMed Web of Science ®Google Scholar
Megarbane B, Karyo S, Baud FJ. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta‐blocker poisoning. Toxicol Rev. 2004;23:215–222.
PubMedGoogle Scholar
Lheureux PE, Zahir S, Gris M, et al. Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care. 2006;10(3):212.
PubMed Web of Science ®Google Scholar
Page C, Ryan N, Isbister G. The safety of high dose insulin euglycaemic therapy in toxin induced cardiac toxicity. Clin Toxicol. 2018;56(6):389–396.
Web of Science ®Google Scholar
Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267(8):1083–1089.
PubMed Web of Science ®Google Scholar